{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T06:01:29Z","timestamp":1770530489051,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-022-00725-y","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T09:02:51Z","timestamp":1660035771000},"page":"91-97","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Acquired factor V inhibitor with erythema and eosinophilia in a patient with end-stage renal disease"],"prefix":"10.1007","volume":"12","author":[{"given":"Eisuke","family":"Katsuren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1636-7889","authenticated-orcid":false,"given":"Kentaro","family":"Kohagura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Kinjyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Zamami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuto","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanako","family":"Oshiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitsugu","family":"Sunagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Omine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Shinzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Souri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitada","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Yamazato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Ohya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"725_CR1","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","volume":"109","author":"PW Collins","year":"2007","unstructured":"Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, et al. Acquired haemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors\u2019 Organisation. Blood. 2007;109:1870\u20137.","journal-title":"Blood"},{"key":"725_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1055\/s-0041-1740149","volume":"48","author":"A Ichinose","year":"2022","unstructured":"Ichinose A, Osaki T, Souri M. A review of coagulation abnormalities of autoimmune acquired factor V deficiency with a focus on Japan. Semin Thromb Hemost. 2022;48:206\u201318.","journal-title":"Semin Thromb Hemost"},{"key":"725_CR3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12185-018-2561-9","volume":"109","author":"H Ogawa","year":"2019","unstructured":"Ogawa H, Souri M, Kanouchi K, Osaki T, Ohkubo R, Kawanishi T, et al. A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis. Int J Hematol. 2019;109:214\u201320.","journal-title":"Int J Hematol"},{"key":"725_CR4","first-page":"667","volume":"60","author":"A Ichinose","year":"2019","unstructured":"Ichinose A. Immune-mediated acquired coagulation factor deficiencies: state-of-the-art in diagnosis and management. Rinsho Ketsueki. 2019;60:667\u201379 (In Japanese).","journal-title":"Rinsho Ketsueki"},{"key":"725_CR5","first-page":"129","volume":"84","author":"A Ichinose","year":"2022","unstructured":"Ichinose A, Hideo W, Hidesaku A. Guidance for diagnosis and management of patients with Japan\u2019s designated disease 288\u20134 autoimmune acquired coagulation factor V\/5 deficiency (AiF5D). Ketsueki Naika. 2022;84:129\u201342 (In Japanese).","journal-title":"Ketsueki Naika"},{"key":"725_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1055\/s-0041-1735452","volume":"48","author":"F Chiurazzi","year":"2022","unstructured":"Chiurazzi F, Tufano A, Esposito M, D\u2019Agostino F, Casoria A, Capasso F, et al. Acquired factor V inhibitor after Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost. 2022;48:124\u20136.","journal-title":"Semin Thromb Hemost"},{"key":"725_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11239-010-0529-6","volume":"31","author":"M Franchini","year":"2011","unstructured":"Franchini M, Lippi G. Acquired factor V inhibitors: a systematic review. J Thromb Thrombolysis. 2011;31:449\u201357.","journal-title":"J Thromb Thrombolysis"},{"key":"725_CR8","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.26420\/annhematoloncol.2017.1173","volume":"4","author":"F Boland","year":"2017","unstructured":"Boland F, Shreenivas AV. Acquired factor V inhibitors: a review of the literature. Ann Hematol Oncol. 2017;4:1168.","journal-title":"Ann Hematol Oncol"},{"key":"725_CR9","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2019.190240","author":"M Yamanishi","year":"2019","unstructured":"Yamanishi M, Nishimi Y, Usui M, Miki K, Imashuku S. Acquired factor V deficiency associated with CFPM administration. Clin Lab. 2019;65(10). https:\/\/doi.org\/10.7754\/Clin.Lab.2019.190240.","journal-title":"Clin Lab"},{"key":"725_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2169\/internalmedicine.9150-17","volume":"57","author":"K Nakata","year":"2018","unstructured":"Nakata K, Ueda S, Matsunaga H, Mima F, Ueda H, Yoshioka A, et al. High titer of acquired factor V inhibitor presenting with a pseudo-deficiency of multiple coagulation factors. Intern Med. 2018;57:393\u20137.","journal-title":"Intern Med"},{"key":"725_CR11","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.12998\/wjcc.v7.i17.2556","volume":"7","author":"WB Zhao","year":"2019","unstructured":"Zhao WB, Chen YR, Luo D, Lin HC, Long B, Wu ZY, et al. Severe serous cavity bleeding caused by acquired factor V deficiency associated with lymphatic leakage in a hemodialysis patient: a case report. World J Clin Cases. 2019;7:2556\u201361.","journal-title":"World J Clin Cases"},{"key":"725_CR12","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.2169\/internalmedicine.55.7369","volume":"55","author":"A Kitazawa","year":"2016","unstructured":"Kitazawa A, Misawa H, Nagahori K, Koda R, Yoshino A, Kawamoto S, et al. Acquired factor V inhibitors in a patient with end-stage renal disease. Intern Med. 2016;55:3505\u20139.","journal-title":"Intern Med"},{"key":"725_CR13","first-page":"445","volume":"61","author":"A Matsumoto","year":"2020","unstructured":"Matsumoto A, Ogawa Y, Osaki T, Souri M, Yanagisawa K, Ishizaki T, et al. Successful management of acquired factor V deficiency developing shortly after induction of hemodialysis. Rinsho Ketsueki. 2020;61:445\u201350 (In Japanese).","journal-title":"Rinsho Ketsueki"},{"key":"725_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s13730-016-0229-y","volume":"5","author":"N Niwa","year":"2016","unstructured":"Niwa N, Yoshida T, Mizuno R, Oya M, Hayashi M. Renal hemorrhage caused by acquired inhibitors to coagulation factors VIII and V in a hemodialysis patient. CEN Case Rep. 2016;5:223\u20136.","journal-title":"CEN Case Rep"},{"key":"725_CR15","first-page":"206","volume":"78","author":"I Ghachem","year":"2020","unstructured":"Ghachem I, El Borgi W, Fekih Salem S, Ben Lakhal F, Chelbi A, Ghiriani I, et al. Haemodialysis Tunisian patient with acquired factor V inhibitor associated to arteriovenous shunt thrombosis. Ann Biol Clin (Paris). 2020;78:206\u20139.","journal-title":"Ann Biol Clin (Paris)"},{"key":"725_CR16","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.4009\/jsdt.36.1285","volume":"36","author":"M Ishizu","year":"2003","unstructured":"Ishizu M, Kuroiwa M, Tanaka K, Hasegawa Y. Severe hemorrhagic tendency due to factor V inhibitor in a hemodialysis patient: a case report. Nihon Toseki Igakkai Zasshi. 2003;36:1285\u20138 (In Japanese, Abstract in English).","journal-title":"Nihon Toseki Igakkai Zasshi."},{"key":"725_CR17","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.2169\/naika.91.3494","volume":"91","author":"N Iino","year":"2002","unstructured":"Iino N, Maruyama H, Gejyo F. Acquired coagulation abnormality due to factor V inhibitor. Nippon Naika Gakkai Zasshi. 2002;91:3295\u20137 (In Japanese).","journal-title":"Nippon Naika Gakkai Zasshi"},{"key":"725_CR18","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/1756-0500-6-553","volume":"6","author":"S Kitamura","year":"2013","unstructured":"Kitamura S, Misawa M, Namba S, Tsuji K, Torigoe R, Shima M, et al. Membranous nephropathy with acquired factor V inhibitor: a case report. BMC Res Notes. 2013;6:553.","journal-title":"BMC Res Notes"},{"key":"725_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00001721-200301000-00016","volume":"14","author":"H Takahashi","year":"2003","unstructured":"Takahashi H, Fuse I, Abe T, Yoshino N, Aizawa Y. Acquired factor V inhibitor complicated by Hashimoto\u2019s thyroiditis, primary biliary cirrhosis and membranous nephropathy. Blood Coagul Fibrinolysis. 2003;14:87\u201393.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"725_CR20","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jid.2021.11.008","volume":"142","author":"Y Mizukawa","year":"2022","unstructured":"Mizukawa Y, Aoyama Y, Takahashi H, Takahashi R, Shiohara T. Risk of progression to autoimmune disease in severe drug eruption: risk factors and the factor-guided stratification. J Investig Dermatol. 2022;142:960-8.e9.","journal-title":"J Investig Dermatol"},{"issue":"Suppl 1","key":"725_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12288-014-0358-4","volume":"30","author":"Y Sekiguchi","year":"2014","unstructured":"Sekiguchi Y, Yoshikawa H, Shimada A, et al. Acquired factor v inhibitor developing after treatment with dabigatran etexilate methanesulfonate: a case report and review of the literature. Indian J Hematol Blood Transfus. 2014;30(Suppl 1):275\u20139.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"725_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-010018","author":"A Khalafallah","year":"2013","unstructured":"Khalafallah A, Grabek J, Hayes R, Mohamed M. Bleeding associated with acquired factor V inhibitor in a patient on warfarin treated successfully with prednisolone. BMJ Case Rep. 2013. https:\/\/doi.org\/10.1136\/bcr-2013-010018.","journal-title":"BMJ Case Rep"},{"key":"725_CR23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1182\/blood.V56.5.835.835","volume":"56","author":"J Chediak","year":"1980","unstructured":"Chediak J, Ashenhurst JB, Garlick I, Desser RK. Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions. Blood. 1980;56:835\u201341.","journal-title":"Blood"},{"key":"725_CR24","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1111\/hae.12915","volume":"22","author":"MD Patel","year":"2016","unstructured":"Patel MD, Hajdenberg J. Successful treatment of chronic recurrent life-threatening bleeding due to an acquired factor V inhibitor with rituximab and steroids. Haemophilia. 2016;22:e231\u20132.","journal-title":"Haemophilia"},{"key":"725_CR25","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/ajh.23241","volume":"87","author":"MA Navarrete","year":"2012","unstructured":"Navarrete MA, van der Meer FJ, Damiani G, Diaz A, Eikenboom J. The use of rituximab therapy in patients with acquired factor V inhibitors. Am J Hematol. 2012;87:826\u20137.","journal-title":"Am J Hematol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00725-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-022-00725-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00725-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:58:32Z","timestamp":1744203512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-022-00725-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["725"],"URL":"https:\/\/doi.org\/10.1007\/s13730-022-00725-y","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"assertion":[{"value":"12 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have declared no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human\u00a0participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient and his family for publication of this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}